Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Asia Deal Watch: Daiichi Sankyo Pays $200m To Ultragenyx For AAV Technology Access

Apr 03 2020

• By Ian Haydock, Jung Won Shin, and Joseph Haas

Asia Deal Watch

Related Content

Glenmark Sells Gynecology Unit

Jan 23 2020

Agile And Differentiated, AlphaMab Riding High In China Biotech Boom

Jun 08 2016

Ono Bulks Up MAb R&D With Second Swiss Biotech Deal

Nov 09 2017

Deal Watch: Harbour Expands Horizons Beyond China

Aug 21 2018

Glenmark Spins Out Business To Drive Value

Aug 13 2018

Alvotech And DKSH Partner On Adalimumab In Asia

Mar 26 2020

Neuraxpharm Buys Glenmark’s Polish CNS Assets

Feb 25 2020

Japan’s AGC Makes Agreed €240m Bid For MolMed

Mar 17 2020

GTS Alliance Gives Mochida A Cell Therapy Buy-In

Mar 25 2020

CytomX’s Probody T-Cell Platform Produces Astellas Pact

Mar 25 2020

Aurobindo-Sandoz End $1bn US Deal

Apr 02 2020

Related Companies

Alvotech

Astellas Pharma, Inc.

CytomX Therapeutics, Inc.

Daiichi Sankyo Co., Ltd.

Ultragenyx Pharmaceutical Inc.

Innovent Biologics, Inc.

Alector, Inc.

Ono Pharmaceutical Company, Ltd.

Numab Therapeutics AG

Alphamab Oncology

Simcere Pharmaceutical Group

Healios K.K.

Athersys, Inc.

Novartis AG

Asahi Kasei Corporation

SBI Biotech Co., Ltd.

Glenmark Pharmaceuticals Limited

Neuraxpharm Arzneimittel GmbH

Alteogen Inc.

Evotec SE

Ildong Pharmaceutical Co., Ltd.

RIBOMIC, Inc.

Context Therapeutics, Inc.

Aurobindo Pharma Limited

Novartis AG

Additional Topics

Asia Pacific Deals Business Strategies M & A Commercial BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window